Ayse Kaplan*
Faculty of Science, Department of Molecular Biology, Eskisehir Technical University, Eskisehir, Turkey
*Corresponding Author: Ayse Kaplan, Molecular Biologist, Faculty of Science, Department of Molecular Biology, Eskisehir Technical University, Eskisehir, Turkey.
Received: February 23, 2023; Published: February 24, 2022
Nanomedicine has emerged as a major field of academic research with direct impact on human health [1]. Rapid growth in nanotechnology towards the improvement of nanomedicine products commits great prospect to develop therapeutic strategies against cancer. Nanomedicine products represent an opportunity to get advanced targeting strategies and multi-functionality [2]. Nanomedicine assists in maintaining a balance between efficacy and toxicity by specifically accumulating in tumors [3]. The advances in nanotechnology as well as cancer biology have enhanced improvement of drug delivery systems for cancer management with enhanced efficacy and limited side effects. Among them, a variety of nanomaterials based on natural/synthetic polymers, liposomes, metal-organic frameworks (MOFs), gold nanoparticles (NPs) and silica NPs have been used to co-deliver cancer agents and other therapeutics with purpose reducing drug side effects [4].
Citation: Ayse Kaplan. “Nanomedicine in Cancer Therapy: Recent Advances and Perspectives" Acta Scientific Cancer Biology 7.1 (2023): 20-21.
Copyright: © 2022 Ayse Kaplan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.